The quest for a single-pill once-a-day treatment for HIV became a reality when the FDA approved Atripla on July 12. It combines the already approved drugs efavirenz (Sustiva), tenofovir (Viread), and ...
HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but ...
The Food and Drug Administration has approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections. The drug will be ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...
The Food and Drug Administration approved a new daily drug that delivers four different HIV medications in one dose. The pill combines four HIV drugs: elvitegravir, cobicistat, emtricitabine, and ...
A Delhi man was left critically ill after taking HIV preventive medication on an AI chatbot's advice without medical supervision. Pre-Exposure Prophylaxis (PrEP) is proven for HIV prevention when ...
Explore the potential of the HIV drug Maraviroc in slowing glioblastoma growth as discovered by McMaster University ...
Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results